Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

MICHAEL BRADY LYNCH BLOG

Latest News

 

Recognized as one of the most experienced and successful mass tort law firms in the country and nationally regarded for our expertise in pharmaceutical and complex litigation.

PIP Insurance Coverage Florida: How it Works

PIP Insurance Coverage Florida: How it Works

Florida is one of 12 “no-fault” insurance states, requiring drivers to carry Personal Injury Protection (PIP) insurance on vehicles operated in the state. PIP insurance allows injured drivers to receive compensation for damages and medical expenses by utilizing their insurance coverage.

An Update on PFAS Cases: New Contamination Sites in US

An Update on PFAS Cases: New Contamination Sites in US

Per- and polyfluoroalkyl substances (PFAS), commonly known as “forever chemicals,” have been a growing concern due to their persistence in the environment and potential health risks. Recent developments have highlighted new contamination sites and legal actions aimed at addressing these issues across the United States.

Nursing Home Abuse: An Overview

Nursing Home Abuse: An Overview

Nursing home abuse involves the mistreatment, neglect, or exploitation of residents in long-term care facilities. This includes skilled nursing homes, assisted living facilities, and other institutions responsible for the care of elderly or vulnerable adults. Under both federal and state laws, these facilities are required to provide residents with a safe, dignified, and compassionate environment.

Oxbryta Recall: What You Need to Know

Oxbryta Recall: What You Need to Know

Oxbryta is a prescription medication developed to help people with sickle cell disease (SCD). It works by improving the oxygen-carrying ability of red blood cells and reducing the complications that come with SCD, like pain crises and organ damage. While it’s been seen as a breakthrough for managing this condition, a recent recall has raised serious concerns about its safety.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 6 other subscribers

Recent Comments

    ×
    What Our Clients Are Saying